Moderna added $44B in a day. Its last 10-Q warned twice.
The readout that tripled Moderna is in no SEC filing. Its 10-Q, three weeks earlier, said the data was coming — and that another Phase 3 had just missed.
4 primary sourcesTicker · 1 article
MRK
Every article on this page was built from the company's own filings. The documents they were read from are listed below, so you can check any figure yourself.
Last checked Aug 24, 2026All companies
Primary sources used
- Moderna, Inc. — Form 10-Q, quarter ended June 30 2026Financials, the Merck collaboration note, the pipeline paragraph quoted here, and 399,235,889 shares outstanding
- Moderna, Inc. — SEC EDGAR filing history (CIK 0001682852)Nothing has been filed since 12 August 2026 · re-verified 24 August 2026
- Daily closing prices, MRNA, February–August 2026 (market data, not a filing)All share prices quoted here · prices may be delayed and are not from a filing
- Press coverage of the readout, 19 August 2026 (news, not a filing)Cited as the claim this article tests against the filings, not as evidence for it
4documents, deduplicated. Links go to the original filing, not to a summary.